Related Experiment Video
Updated: Apr 22, 2026

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery
Published on: February 28, 2020
Knockdown of EIF3D suppresses proliferation of human melanoma cells through G2/M phase arrest
Hui Li1, Fusheng Zhou1, Hongyan Wang1
1Department of Dermatology, Institute of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, People's Republic of China.
Abstract:
Skin cancer is the most common malignancy with increasing incidence rates worldwide. The advanced form of skin cancer, melanoma, is resistant to conventional treatment methods, which motivated researchers to identify an alternative effective therapeutic approach. This study was designed to identify the effects of small interfering RNA (si-RNA) mediated silencing of eukaryotic translation initiation factor 3, subunit D (EIF3D) against melanoma cell survival. Briefly, a lentivirus-mediated RNA interference system was employed to knock down EIF3D expression in A375 and A431 melanoma cells. The cell proliferation was analyzed by methylthiazoletetrazolium (MTT) and colony formation assays. The cell cycle progression was investigated using flow cytometry. Results revealed that si-RNA-mediated knockdown of EIF3D significantly reduced the gene and protein expression levels of EIF3D in melanoma cells. Furthermore, knockdown of EIF3D led to a significant reduction in cell proliferation due to G2 /M phase cell cycle arrest. Apparently, the study demonstrated the critical involvement of EIF3D in the survival and progression of melanoma cells and depletion of EIF3D could be developed as a possible therapeutic option in the gene-targeted treatment of melanoma.
Insights
Targeting eukaryotic translation initiation factor 3, subunit D (EIF3D) with small interfering RNA (siRNA) effectively inhibits melanoma cell survival. Silencing EIF3D causes cell cycle arrest and reduces proliferation, offering a potential gene-targeted therapy for melanoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Skin cancer, particularly melanoma, is a prevalent malignancy with increasing incidence.
- Advanced melanoma exhibits resistance to conventional therapies, necessitating novel treatment strategies.
- Eukaryotic translation initiation factor 3, subunit D (EIF3D) role in melanoma progression requires elucidation.
Purpose of the Study:
- To investigate the therapeutic potential of silencing EIF3D using small interfering RNA (siRNA) in melanoma.
- To determine the impact of EIF3D knockdown on melanoma cell survival and proliferation.
- To analyze the effect of EIF3D inhibition on melanoma cell cycle progression.
Main Methods:
- Lentivirus-mediated RNA interference was used to achieve EIF3D knockdown in A375 and A431 melanoma cell lines.
- Cell proliferation was assessed using methylthiazole tetrazolium (MTT) and colony formation assays.
- Cell cycle progression was analyzed via flow cytometry.
Main Results:
- siRNA-mediated EIF3D knockdown significantly reduced both gene and protein expression of EIF3D in melanoma cells.
- EIF3D knockdown resulted in a substantial decrease in melanoma cell proliferation.
- Inhibition of EIF3D induced a G2/M phase cell cycle arrest in melanoma cells.
Conclusions:
- EIF3D plays a critical role in the survival and progression of melanoma cells.
- Depletion of EIF3D demonstrates significant anti-melanoma effects.
- Targeting EIF3D represents a promising therapeutic strategy for gene-targeted melanoma treatment.
Related Concept Videos
Mitogens and the Cell Cycle
Inhibition of Cdk Activity
Abnormal Proliferation
Negative Regulator Molecules

